Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence.
- DOI
- 10.3389/fdsfr.2026.1836444
- Published
- 2026
- Container
- Frontiers in drug safety and regulation
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fdsfr.2026.1836444,
title = {Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence.},
author = {Sošić M and Rački V and Fajkić A and Jašić M and Belančić A},
year = {2026},
journal = {Frontiers in drug safety and regulation},
doi = {10.3389/fdsfr.2026.1836444},
url = {https://doi.org/10.3389/fdsfr.2026.1836444}
}RIS
TY - JOUR TI - Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence. AU - Sošić M AU - Rački V AU - Fajkić A AU - Jašić M AU - Belančić A PY - 2026 JO - Frontiers in drug safety and regulation DO - 10.3389/fdsfr.2026.1836444 UR - https://doi.org/10.3389/fdsfr.2026.1836444 ER -
APA
M, S., V, R., A, F., M, J., & A, B. (2026). Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence.. Frontiers in drug safety and regulation. https://doi.org/10.3389/fdsfr.2026.1836444